Targeting Nicotinic Receptors for Parkinson's Disease Therapy

E-ISSN： 1996-3181|10|6|651-658

ISSN： 1871-5273

Source： CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol.10, Iss.6, 2011-09, pp. : 651-658

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Nicotinic receptors and Parkinson's disease

By Quik M. Jeyarasasingam G.

European Journal of Pharmacology, Vol. 393, Iss. 1, 2000-03 ,pp. : 223-230

Elsevier

Access to resources Recommend Favorite

Plausible Improvements for Selective Targeting of Dopamine Receptors in Therapy of Parkinson's Disease

Mini Reviews in Medicinal Chemistry, Vol. 12, Iss. 14, 2012-12 ,pp. : 1556-1564

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting the Nicotinic Acetylcholine Receptors (nAChRs) in Astrocytes as a Potential Therapeutic Target in Parkinson’s Disease

Current Pharmaceutical Design, Vol. 22, Iss. 10, 2016-03 ,pp. : 1305-1311

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Neuronal Nicotinic Receptors: a Path to New Therapies

Current Drug Targets-CNS & Neurological Disorders, Vol. 1, Iss. 4, 2002-08 ,pp. : 349-357

Bentham Science Publishers

Access to resources Recommend Favorite

New pharmacological avenues for the treatment of l-DOPA-induced dyskinesias in Parkinson's disease: targeting glutamate and adenosine receptors

By Blandini Fabio Armentero Marie-Therese

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 2, 2012-02 ,pp. : 153-168

Informa Healthcare

Access to resources Recommend Favorite